Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)

Market Cap	5.38B
Revenue (ttm)	7.40B
Net Income (ttm)	420.22M
Shares Out	107.42M
EPS (ttm)	3.90
PE Ratio	12.84
Forward PE	n/a
Dividend	1.40 (2.79%)
Ex-Dividend Date	Nov 20, 2024

Volume	203,720
Open	50.20
Previous Close	50.10
Day's Range	49.50 - 50.70
52-Week Range	36.20 - 118.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 23, 2025

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. The company was incorporated in 1986 and is based in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 4,408
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: NAVANAPHAR

Financial Performance

In 2024, Navana Pharmaceuticals's revenue was 6.90 billion, an increase of 20.89% compared to the previous year's 5.71 billion. Earnings were 404.63 million, an increase of 13.36%.